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Abstract
Aims: To compare the effect of fasting period duration
on complication rates in neonates managed conserva-
tively for necrotizing enterocolitis (NEC) Bell stage II.
Methods: We conducted a multicenter study to analyze
retrospectively multiple data collected by standardized
questionnaire on all admissions for NEC between Janu-
ary 2000 and December 2006. NEC was staged using
modified Bell criteria. We divided the conservatively man-
aged neonates with NEC Bell stage II into two groups
(those fasted for -5 days and those fasted for )5 days)
and compared the complication rates.
Results: Of the 47 conservatively managed neonates
Bell stage II, 30 (64%) fasted for -5 days (range
1–4 days) and 17 (36%) for )5 days (range 6–16 days).
There were no significant differences for any of the
patient characteristics analyzed. One (3%) and four
(24%) neonates, respectively, developed post-NEC bow-
el stricture. One (3%) and two neonates (12%) suffered
NEC relapse. None and five (29%) neonates developed
catheter-related sepsis.
Conclusion: Shorter fasting after NEC appears to lower
morbidity after the acute phase of the disease. In partic-
ular, shorter-fasted neonates have significantly less cath-
eter-related sepsis. We found no benefit in longer fasting.
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Introduction
Necrotizing enterocolitis (NEC) is the most common
acquired intraabdominal emergency in infants w10x and
the most common surgical emergency in the neonatal
intensive care unit (NICU) w11x. Incidences range from
3% to 28%, averaging 6%–10% in infants with birth
weights -1500 g, and incurring a mortality of 10%–30%
w7x. Although the precise cause remains unclear, incrim-
inated factors include impaired immunity of the immature
gut, enteral feeding, and bacterial gut colonization,
although no specific pathogen has been identified w12,
16x.
Treatment of sonographically and radiologically con-
firmed NEC consists of nasogastric decompression, anti-
biotic therapy, total parenteral nutrition (TPN), and
surgery when necessary. There is no standard recom-
mendation for when to reinitiate enteral feeding in non-
surgically treated infants. Textbooks recommend resting
the bowel for 7–10 days w3, 7x. However, the scientific
basis for relatively prolonged fasting is unclear w13x. The
issue of fasting period duration is particularly important
in a NICU such as ours that manages most of its NEC
cases conservatively. We therefore conducted a multi-
center comparison of fasting period duration in conser-
vatively managed NEC Bell stage II to determine its effect
on complications such as bowel stricture, NEC relapse,
and catheter-related sepsis.
Patients and methods
We conducted a retrospective analysis of all term and preterm
neonates with NEC (ns124) admitted to five Swiss NICUs
between January 2000 and December 2006. All NICUs were
tertiary centers, well equipped for managing sick neonates with
pediatric surgical support. We used data collected by standard-
ized questionnaire. Three NICU questionnaires were filled out
by the same person in the study group and the other two by a
NICU neonatologist. The questionnaires incorporated the inter-
national definition of NEC and the Bell stages w2x. They covered
the following items: fasting period duration (some NICUs fol-
lowed a fixed 5-day regime, others a fixed 10-day regime, but
all often tailored the period according to their individual experi-
ence wfasting period range: 4–14 daysx and modified Bell criteria
w8x); gestational age; birth weight; sex; antenatal steroids; cause
of prematurity; umbilical catheterization; patent ductus arterio-
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Table 1 Patient characteristics (ns124).
Therapy
Conservative Surgical Bell III P-value
Bell I and II
Patients, n (%) 75 (60) 49 (40)
Female 34 (45) 23 (47) 0.85
Male 41 (55) 26 (53) 0.85
Gestational age, weeks (mean"1 SD) 31.4"2.8 28.9"3.4 -0.0001
Birth weight
g (mean"1 SD) 1519"540 1151"541 0.0003
-10th percentile, n (%) 12 (16) 4 (8) 0.28
Cesarean section, n (%) 69 (92) 40 (81) 0.1
Antenatal steroids, n (%) 54 (72) 35 (71) )0.99
Maternal disease, n (%)
Preeclampsia 15 (20) 13 (27) 0.5
Amniotic infection 15 (20) 10 (20) )0.99
Placental abruption 8 (11) 10 (20) 0.19
Catheter, n (%)
Umbilical venous 11 (15) 17 (35) 0.009
Umbilical arterial 23 (31) 20 (41) 0.56
Initial respiratory support, n (%)
Ventilator 23 (31) 23 (47) 0.06
NCPAP 22 (29) 16 (33) 0.84
Surfactant therapy 25 (33) 20 (41) 0.35
Bronchopulmonary dysplasia, n (%) 5 (7) 5 (10) 0.51
Patent ductus arteriosus, n (%) 10 (13) 19 (39) 0.002
Indomethacin therapy, n (%) 10 (13) 17 (35) 0.008
IVH )grade II, n (%) 3 (4) 6 (12) 0.16
Retinopathy of prematurity )grade II, n (%) 0 (0) 1 (1) 0.4
nsnumber, SDsstandard deviation, NCPAPsnasal continuous positive airways pressure, IVHsintraventricular hemorrhage.
sus; initial ventilatory support; surfactant replacement; indo-
methacin therapy; and concomitant disease (bronchopulmonary
dysplasia, retinopathy of prematurity, intraventricular hemor-
rhage (IVH), and periventricular leukomalacia). Retinopathy of
prematurity and IVH were defined as significant if )grade II
w9–11, 15, 17, 20x. Patent ductus arteriosus based on echocar-
diologic criteria qualified only if it required treatment (indometh-
acin or surgery). Diagnostic data for NEC related to clinical signs,
cultures (blood and stool), and imaging (X-ray). Therapy and
complication variables included circulatory and/or ventilatory
support during the acute phase of NEC, surgery versus conser-
vative management, antibiotic therapy, TPN duration, short bow-
el syndrome, bowel stricture (defined as significant if suspected
clinically, confirmed radiographically and requiring surgery in the
neonatal period), NEC relapse, and catheter-related sepsis.
Catheter-related sepsis was diagnosed using the Centers for
Disease Control criteria: clinical signs of sepsis, one positive
peripheral blood culture, and negative urine and tracheal aspi-
rate cultures w14x.
All neonates included in Bell stage II showed the same clas-
sical clinical and radiologic signs. For that reason all neonates
with radiologic pneumatosis intestinalis and/or portal venous
gas were staged Bell II. Neonates with metabolic acidosis
(pH-7.2), receiving inotropes or mechanical ventilation were
staged Bell III. The retrospective design made subtle distinction
between Bell stages IIa and IIb impossible.
Since conservatively managed neonates in Bell stage II were
our primary focus, we subdivided the infants concerned into
those fasted for-5 days and those fasted for)5 days to permit
comparison of complication rates, primarily bowel stricture, NEC
relapse, and catheter-related sepsis. We chose the 5-day cut-
off because it was half the duration of the longest standard
regime (10 days) in any NICU. We focused on neonates in Bell
stage II, because the criteria of Bell stage I (suspected NEC) are
quite vague, with the potential for inconsistent reporting and
classification. We also excluded Bell stage III neonates because
all required surgery.
After different fasting periods in the individual NICUs, the
same feeding algorithm was implemented. It comprised 10
mL/kg body weight (BW) solution by gastric tube in 12 or 8 por-
tions/d on day 1 (D1), 10 mL/kg BW breast milk or formula milk
on D2, increasing by 20 mL/kg BW/d to 140–150 mL/kg BW/d.
Statistical analysis: we analyzed normally distributed contin-
uous variables using the unpaired t-test and categorical
variables using Fisher’s exact test.
Results
The total population of 124 infants with Bell stage I–III
NEC included five term and 119 preterm neonates
(-32 weeks, ns89; G32 weeks, ns30). Over the 7-year
study period, the five NICUs admitted 2005 inborn pre-
term neonates aged -32 weeks, giving an incidence of
NEC of 4.4% in this age group. Treatment was conser-
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Table 2 Patient characteristics of conservatively managed necrotizing enterocolitis Bell stage II.
Fasting period
-5 days )5 days P-value
Patients, n (%) 30 (64) 17 (36)
Female 12 (40) 7 (41) )0.999
Male 18 (60) 10 (59) )0.999
Gestational age, weeks (mean"1 SD) 32.0"2.8 31.7"3.0 0.77
Birth weight
g (mean"1 SD) 1717"560 1545"535 0.3
-10th percentile, n (%) 3 (10) 0 0.29
Cesarean section, n (%) 28 (93) 16 (94) )0.999
Antenatal steroids, n (%) 24 (80) 12 (71) 0.49
Maternal disease, n (%)
Preeclampsia 5 (17) 5 (29) 0.46
Amniotic infection 6 (20) 4 (24) )0.999
Placental abruption 5 (17) 2 (12) )0.999
Initial respiratory support, n (%)
Ventilator 8 (27) 6 (35) 0.74
NCPAP 8 (27) 4 (24) )0.999
Surfactant therapy 7 (23) 5 (29) 0.73
Bronchopulmonary dysplasia, n (%) 1 (3) 1 (6) )0.999
Catheter, n (%)
Umbilical venous 4 (13) 3 (18) 0.68
Umbilical arterial 9 (30) 6 (35) 0.75
Patent ductus arteriosus, n (%) 5 (17) 2 (12) )0.999
Indomethacin therapy, n (%) 5 (17) 2 (12) )0.999
IVH )grade II, n (%) 1 (3) 0 )0.999
Retinopathy of prematurity )grade II, n (%) 1 (3) 1 (6) )0.999
Age at NEC onset, days (mean"1 SD) 8.6"7.8 9.4"9.0 0.74
Positive blood cultures at NEC diagnosis, n (%) 2 (7) 3 (18) 0.34
Blood in stool, n (%) 30 (100) 10 (59) 0.0003
Pneumatosis intestinalis, n (%) 30 (100) 17 (100) )0.999
TPN administered, days (mean"1 SD) 14.9"4.0 18.5"5.9 0.02
nsnumber, NCPAPsnasal continuous positive airways pressure, NECsnecrotizing enterocolitis, SDsstandard deviation, IVHs
intraventricular hemorrhage, TPNstotal parenteral nutrition.
Table 3 Complications in conservatively managed necrotizing
enterocolitis Bell stage II.
Fasting period
-5 days )5 days P-value
Catheter-related sepsis, n (%) 0 5 (29) 0.004
Early post-NEC stricture, n (%) 1 (3) 4 (24) 0.05
NEC relapse, n (%) 1 (3) 2 (12) 0.27
nsnumber, NECsnecrotizing enterocolitis.
vative in 75/124 neonates (60.5%) and surgical in 49
(39.5%). Surgically treated neonates were more seriously
ill and of lower gestational age (Table 1).
Of the 75 conservatively managed neonates, 28 (37%)
were classified as Bell stage I and 47 (63%) as Bell stage
II. Of the neonates classified as Bell stage II, 30 (64%)
fasted for -5 days (range 1–5 days; NICU1 ns28,
NICU2 ns2, NICU3–5 ns0) and 17 (36%) for )5 days
(range 6–16 days; NICU1 ns3, NICU2 ns7, NICU3
ns4, NICU4 ns3, NICU5 ns0). All were preterm except
for two and one neonates, respectively. Characteristics
of the groups did not differ (Table 2) except for ‘‘blood in
stool’’, which was less frequent in neonates with fasting
period )5 days (Ps0.0003). Ages at NEC symptom
onset (mean, SD) were 8.6"7.8 and 9.4"9.0 days
(Ps0.74). TPN was administered for 14.9"4.0 and
18.5"5.9 days (Ps0.02). Neonates in the -5 days
group needed 14.9"4.0 (range 8–25) days of fasting
until initiation of full enteral nutrition vs. 18.5"5.9 (range
10–36) days needed by those in the )5 days group
(Ps0.02).
Complications (Table 3)
None and five neonates (29%; NICU1 ns1, NICU2 ns2,
NICU3 ns2, NICU4/5 ns0) developed catheter-related
sepsis, a single episode in all cases (Ps0.004). Blood
cultures yielded coagulase-negative Staphylococcus
(ns5). One (3%) and four neonates (24%) required sur-
gery for early post-NEC stricture (Ps0.05); all had evi-
dence of ileus with vomiting, abdominal distension, and
confirmatory radiology. One (3%) and two neonates
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(12%) relapsed (Ps0.27), with symptom onset ranging
from 3 to 4 weeks after the initial episode; one was treat-
ed conservatively, the other two surgically. Stricture and
relapse rates tended to be lower in the shorter-fasted
group. No neonate developed short bowel syndrome and
none died.
Discussion
Despite many studies of enteral feeding before the onset
of NEC w18x, data are lacking on the timing of enteral re-
feeding after NEC, hence the absence of consensus
guidelines. A 1975 report associated relapse in ‘‘several
patients’’ with the reintroduction of enteral feeding
-10 days after NEC w8x. Textbooks offer the unsubstan-
tiated recommendation to rest the bowel for 7–10 days
w3, 7x. However, a 2003 study concluded that early
enteral feeding after NEC was associated with significant
benefits and no apparent adverse effects w5x. Early re-
feeding may have a healing effect or, at least, helps
recovery of the intestinal mucosa. Local trophic nutrients
support and stimulate mucosal growth and may thus be
protective. In contrast, in the absence of enteral feeding,
mucosal villous atrophy may occur within one week, pre-
disposing to recurrent intestinal injury and feeding intol-
erance w4, 12x.
Our analysis of five Swiss neonatal units mirrors the
variability in the literature over post-NEC re-feeding.
Although each unit practices the same re-feeding regime,
they differ in their belief as to when re-feeding should
start, in particular, in conservatively managed stage II
NEC. Whereas one unit has already managed to signifi-
cantly shorten the fasting period, the other units, despite
the same severity of NEC, are still equivocal over the
introduction of advanced re-feeding. Individual experi-
ence is still much too often at work. This raises the ques-
tions: When is the right time to re-feed in stage II NEC
and are long fasting periods actually counterproductive?
Our retrospective study shows that early enteral feed-
ing in conservatively managed NEC stage II is associated
with less catheter-related sepsis, which may be related
to the shorter requirement for TPN, but our data also
reveal no adverse effects of shorter fasting. On the con-
trary, the rates of bowel stricture (3% vs. 24%) showed
only borderline significance and relapse (3% vs. 12%)
tended to be lower than in longer-fasted neonates.
Assuming an NEC relapse rate of roughly 6% (for con-
servatively managed neonates) in this study, 356 patients
would be required per treatment arm to have a modest
chance of detecting a doubling of the NEC relapse rate
(80% power, at 0.05 significance level). With only 17
patients in one of the treatment arms, this study was
underpowered for detecting this clinically important
outcome (it was only powered to detect a difference
in relapse rates of 6% vs. 45%).
Early stricture, within the neonatal period, is quite a
common complication of NEC. It occurs in conservatively
managed neonates as well as in those treated surgically,
and is presumably due to post-ischemic scarring w1x.
Treatment is always surgical. No specific (including bac-
teriological) criteria have succeeded in predicting which
patients are at risk of stricture after conservative man-
agement w6x. The incidences in our study, namely 3%
and 24%, were somewhat lower than the 16%–37%
reported in the literature w6, 19x.
The incidence of NEC in our overall population of pre-
term neonates -32 weeks, 4.4%, was within the report-
ed range w3, 7, 12x. Similarly, our relapse rates in
conservatively managed neonates, 3% and 12%, were
also consistent with the literature w3, 9x despite potential
inconsistencies in reporting this parameter: The five
NICUs differed in their interpretation of certain signs (e.g.,
blood in the stool), and did not always classify them as
relapse.
Despite our study’s limitations, e.g., its retrospective
design, our observations suggest that early enteral feed-
ing after conservatively managed NEC stage II may lower
morbidity after the acute phase of the disease. In partic-
ular, neonates fasting for a shorter period had signifi-
cantly less catheter-related sepsis. We failed to identify
any benefit in longer fasting.
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